Olumuyiwa Adeboye, MD
Hospice and Palliative Medicine · Lagrange, GANPI 1720261407
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 119 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 10.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $972, more than ten times the $87 reported in 2022. Among hospice and palliative medicine clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 119 payments — averaging $19.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$243
- Daiichi Sankyo Inc.$228
- Novartis$205
- AstraZeneca$166
- Pfizer$112
- Takeda Pharmaceuticals U.S.A., Inc.$110
- plus $1K from 34 others
What the payments were for
- Food & beverage$2,33699%
- Education$311%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 12 | $243 |
| Daiichi Sankyo Inc. | 11 | $228 |
| Novartis | 9 | $205 |
| AstraZeneca(2 entities) | 9 | $166 |
| Pfizer | 6 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $110 |
| Johnson & Johnson | 6 | $103 |
| Jazz Pharmaceuticals Inc. | 4 | $87 |
| Sobi, Inc | 4 | $80 |
| Eisai Inc. | 4 | $67 |
| Stemline Therapeutics Inc. | 3 | $66 |
| Incyte Corporation | 3 | $62 |
| Lilly USA, LLC | 3 | $58 |
| GSK | 3 | $52 |
| Boehringer Ingelheim | 2 | $51 |
| Regeneron Healthcare Solutions, Inc. | 2 | $47 |
| Sanofi | 2 | $41 |
| Pharmacosmos Therapeutics Inc. | 2 | $38 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| Exelixis Inc. | 2 | $36 |
| Adaptive Biotechnologies Corporation | 2 | $36 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| AVEO Pharmaceuticals, Inc. | 2 | $34 |
| Rigel Pharmaceuticals, Inc. | 2 | $32 |
| Gilead | 2 | $30 |
| Siemens Medical Solutions USA, Inc. | 1 | $28 |
| CSL Behring | 1 | $27 |
| Geron Corporation | 1 | $26 |
| Cvrx, Inc. | 1 | $22 |
| Karyopharm Therapeutics Inc. | 1 | $22 |
| Dendreon Pharmaceuticals LLC | 1 | $21 |
| Myriad Genetic Laboratories, Inc. | 1 | $20 |
| Coherus Oncology, Inc. | 1 | $20 |
| Iovance Biotherapeutics, Inc. | 1 | $19 |
| G1 Therapeutics, Inc. | 1 | $19 |
| Myovant Sciences Inc. | 1 | $18 |
| Boston Scientific | 1 | $17 |
| Tolmar, Inc. | 1 | $17 |
| Bayer | 1 | $17 |
| Deciphera Pharmaceuticals Inc. | 1 | $17 |
How this compares
$2,367 in reported general payments places this provider in the 90th percentile of 69 hospice and palliative medicine providers in Georgia.
See all hospice and palliative medicine providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 22 | $2,187 |
| Sucralfate | 14 | $1,301 |
| Morphine Sulfate | 53 | $1,201 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 66 | $1,004 |
| Oxycodone Hcl | 50 | $887 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 55 | $714 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 17 | $585 |
| Hydromorphone Hcl | 28 | $529 |
| Morphine Sulfate ErMorphine Sulfate | 22 | $521 |
| Ondansetron Hcl | 36 | $440 |
| Mirtazapine | 29 | $424 |
| Oxybutynin Chloride ErOxybutynin Chloride | 13 | $346 |
| Quetiapine Fumarate | 29 | $311 |
| Ondansetron OdtOndansetron | 18 | $292 |
| Gabapentin | 33 | $284 |
Paid to pharmacies, not to this prescriber.
Other hospice and palliative medicine in Lagrange
- Gail KnightLagrange$22
- Veronica SudekumWarner Robins$7K
- Anthony EkwenchiAustell$5K
- Joshua JacksonAtlanta$5K
- Nokuthula MsimangaMarietta$3K
- Halima DaboikoKennesaw$3K
- Michelle ParkMarietta$2K
- Mary KeithGainesville$2K
- Tanya NikolovaMarietta$1K
- Christina ChenMarietta$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.